Skip to main content

Table 4 The comparison of C4-acylcarnitine and/or EMA values in the cohort of SCAD-deficient patients and control groups B and C, respectively

From: An unusually high frequency of SCAD deficiency caused by two pathogenic variants in the ACADS gene and its relationship to the ethnic structure in Slovakia

C4-acylcarnitine (μmol.l− 1)

control group B (n = 90)

patients (n = 48)

mean value ± SD

0.19 ± 0.07

1.64 ± 0.64*

minimal/maximal value

0.07/0.40

0.44/3.63

EMA (μmol/mmol creatinine)

control group C (n = 52)

patients (n = 36)

mean value ± SD

6.96 ± 3.44

396 ± 249*

minimal/maximal value

0.84/15.96

54/1070

  1. Data are shown as the mean ± SD
  2. *statistical significance P < 0.01